Aurinia Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.3M | 86k | 14.82 |
| 2025-12-31 | $1.1M | 67k | 15.96 |
| 2025-09-30 | $689k | 62k | 11.06 |
| 2025-06-30 | $497k | 59k | 8.47 |
| 2025-03-31 | $475k | 59k | 8.05 |
| 2024-12-31 | $468k | 52k | 8.98 |
| 2024-09-30 | $321k | 44k | 7.34 |
| 2024-06-30 | $261k | 46k | 5.71 |
| 2024-03-31 | $196k | 39k | 5.03 |
| 2023-12-31 | $305k | 34k | 9.00 |
| 2023-09-30 | $237k | 30k | 7.80 |
| 2023-06-30 | $266k | 27k | 9.70 |
| 2023-03-31 | $285k | 26k | 10.99 |
| 2022-12-31 | $99k | 23k | 4.30 |
| 2017-03-31 | $5.5M | 751k | 7.34 |